Nectr, the functional oral pouch company behind “The Functional Pouch Category,” today launched Focus+, its most loaded nootropic pouch and the new flagship product in the brand’s lineup. Focus+ is now available to customers across the United States.
Focus+ is a 320 mg+ blend of seven active ingredients in a single sachet: L-Theanine (100 mg), Alpha-GPC (85 mg), L-Tyrosine (85 mg), Caffeine (50 mg), Huperzine A (30 mcg), and vitamins B6 and B12 in the bioactive form of methylcobalamin. Sold as a dietary supplement, the pouch is designed to promote concentration, memory, attention and sustained mental energy, with a sublingual effect in 10 to 15 minutes and a concentration window of one to two hours.
Every Focus+ pouch is made in the USA, GMP certified and third-party tested, with no artificial colors or proprietary blends. Each formula prints every milligram on the label. All Nectr sachets contain zero nicotine and zero tobacco.
Focus+ replaces Nectr’s old Focus pouch, which is being discontinued. The new flagship product roughly doubles the caffeine and adds six additional active ingredients compared to the product it succeeds, consolidating the brand’s nootropic offering into a single, fully dosed sachet.
“Focus+ is the most comprehensive cover Nectr has ever designed,” said Jared Martin, co-founder and CEO of Nectr. “It is designed for people who decide how they present themselves. Everyday life demands a lot, and Focus+ brings together seven active ingredients, fully dosed, to promote real concentration.”
The launch expands a positioning that Nectr has held since its inception in 2023. The company defines the daily slide toward autopilot and reliance on stimulants as “drifting,” and its products as a way to stay present and deliberate rather than depending on the spike-and-crash cycle of conventional energy drinks and addiction to nicotine pouches.
Focus+ is launching in four flavors: fresh mint, mango, wintergreen and watermelon. One pouch is placed under the upper lip and is intended to provide a stable concentration block of 60 to 120 minutes, with a stated daily limit of four pouches maximum. The line is sold on its site, on Amazon and at select retailers across the United States. (18 years and over)
“The first exchange is the one that counts,” Jared added. “When someone swaps a habit that’s depleting them for one they actually chose, everything downstream changes. Focus+ is designed to make that first swap easy.”
Nectr enters the launch as oral nootropic and caffeine sachets continue to gain traction among consumers in the United States seeking alternatives to energy drinks and nicotine sachets. The Swedish-style pouch format, long established in Northern Europe, has rapidly expanded into the American functional category in recent years. Product specifications, ingredient details and instructions for use are published on each product listing.
About Nectr
Nectr is a functional pouch company based in San Diego, California, started by three friends who were addicted to energy drinks and tired of the trade-off between peak, crash and addiction. They bet on themselves with four palettes of a Swedish pouch format that no one in America had tried, with a Southern California twist. Today, the brand manufactures oral sachets across three ranges, Energy, Zero and Focus+, positioned as “the stimulation control system” for people seeking clean performance and total discipline.
These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease. Contains caffeine. For adults aged 18 and over. Do not use by people sensitive to caffeine, pregnant or breastfeeding. Nectr sachets do not contain nicotine or tobacco and are not nicotine replacement therapy.
Disclaimer: The information provided in this press release does not constitute an investment solicitation nor is it intended to constitute investment advice, financial advice or trading advice. Investing involves risks, including the potential loss of capital. It is strongly recommended that you perform due diligence, including consulting a professional financial advisor, before investing in or trading cryptocurrencies and securities. Neither the media platform nor the publisher shall be liable for any fraudulent activity, misrepresentation or financial loss arising from the contents of this press release.
